<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_Any5Qrw">Gamification-augmented home-based exercise for peripheral ar ter y disease: Rationale and design of the GAMEPAD Study</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>MD, MHS</roleName><forename type="first">Alexander</forename><forename type="middle">C</forename><surname>Fanaroff</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>a</label> Department of Medicine , Perelman School of Medicine , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department" key="dep1">Department of Medicine</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>b</label> Penn Cardiovascular Outcomes, Quality , and Evaluative Research Center , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department" key="dep1">Penn Cardiovascular Outcomes, Quality</orgName>
								<orgName type="department" key="dep2">Evaluative Research Center</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>c</label> Penn Center for Health Incentives and Behavioral Economics , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department">Penn Center for Health Incentives and Behavioral Economics</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>d</label> Leonard Davis Institute of Health Economics , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department">Leonard Davis Institute of Health Economics</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Samantha</forename><surname>Coratti</surname></persName>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>e</label> Penn Center for Digital Cardiology , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department">Penn Center for Digital Cardiology</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><surname>Ba</surname></persName>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>c</label> Penn Center for Health Incentives and Behavioral Economics , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department">Penn Center for Health Incentives and Behavioral Economics</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>c</label> Penn Center for Health Incentives and Behavioral Economics , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department">Penn Center for Health Incentives and Behavioral Economics</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">David</forename><surname>Farraday</surname></persName>
						</author>
						<author>
							<persName><roleName>MA</roleName><forename type="first">Laurie</forename><surname>Norton</surname></persName>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>c</label> Penn Center for Health Incentives and Behavioral Economics , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department">Penn Center for Health Incentives and Behavioral Economics</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<note type="raw_affiliation"><label>f</label> Department of Medical Ethics and Health Policy , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department">Department of Medical Ethics and Health Policy</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MA</roleName><forename type="first">Charles</forename><surname>Rareshide</surname></persName>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>c</label> Penn Center for Health Incentives and Behavioral Economics , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department">Penn Center for Health Incentives and Behavioral Economics</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MS, MBA</roleName><forename type="first">Jingsan</forename><surname>Zhu</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>a</label> Department of Medicine , Perelman School of Medicine , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department" key="dep1">Department of Medicine</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>c</label> Penn Center for Health Incentives and Behavioral Economics , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department">Penn Center for Health Incentives and Behavioral Economics</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<note type="raw_affiliation"><label>f</label> Department of Medical Ethics and Health Policy , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department">Department of Medical Ethics and Health Policy</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Michael</forename><forename type="middle">G</forename><surname>Levin</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>a</label> Department of Medicine , Perelman School of Medicine , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department" key="dep1">Department of Medicine</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<note type="raw_affiliation"><label>g</label> Corporal Michael J. Crescenz VA Medical Center , Philadelphia , Pennsylvania ,</note>
								<orgName type="institution">Corporal Michael J. Crescenz VA Medical Center</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>Pennsylvania</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Scott</forename><forename type="middle">M</forename><surname>Damrauer</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>b</label> Penn Cardiovascular Outcomes, Quality , and Evaluative Research Center , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department" key="dep1">Penn Cardiovascular Outcomes, Quality</orgName>
								<orgName type="department" key="dep2">Evaluative Research Center</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>d</label> Leonard Davis Institute of Health Economics , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department">Leonard Davis Institute of Health Economics</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<note type="raw_affiliation"><label>g</label> Corporal Michael J. Crescenz VA Medical Center , Philadelphia , Pennsylvania ,</note>
								<orgName type="institution">Corporal Michael J. Crescenz VA Medical Center</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>Pennsylvania</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, MHS</roleName><forename type="first">Jay</forename><forename type="middle">S</forename><surname>Giri</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>a</label> Department of Medicine , Perelman School of Medicine , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department" key="dep1">Department of Medicine</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>c</label> Penn Center for Health Incentives and Behavioral Economics , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department">Penn Center for Health Incentives and Behavioral Economics</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>d</label> Leonard Davis Institute of Health Economics , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department">Leonard Davis Institute of Health Economics</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<note type="raw_affiliation"><label>h</label> Division of Vascular Surgery , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department">Division of Vascular Surgery</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, MBA</roleName><forename type="first">Neel</forename><forename type="middle">P</forename><surname>Chokshi</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>a</label> Department of Medicine , Perelman School of Medicine , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department" key="dep1">Department of Medicine</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>d</label> Leonard Davis Institute of Health Economics , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department">Leonard Davis Institute of Health Economics</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>e</label> Penn Center for Digital Cardiology , University of Pennsylvania , Philadelphia , PA ,</note>
								<orgName type="department">Penn Center for Digital Cardiology</orgName>
								<orgName type="institution">University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<note type="raw_affiliation"><label>g</label> Corporal Michael J. Crescenz VA Medical Center , Philadelphia , Pennsylvania ,</note>
								<orgName type="institution">Corporal Michael J. Crescenz VA Medical Center</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>Pennsylvania</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, MS i</roleName><forename type="first">Benjamin</forename><forename type="middle">M</forename><surname>Jackson</surname></persName>
							<affiliation key="aff9">
								<note type="raw_affiliation"><label>i</label> Division of Vascular Surgery , Lehigh Valley Heart and Vascular Institute , Allentown , PA ,</note>
								<orgName type="department">Division of Vascular Surgery</orgName>
								<orgName type="institution">Lehigh Valley Heart and Vascular Institute</orgName>
								<address>
									<settlement>Allentown</settlement>
									<region>PA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, MBA</roleName><forename type="first">Mitesh</forename><forename type="middle">S</forename><surname>Patel</surname></persName>
							<affiliation key="aff10">
								<note type="raw_affiliation"><label>j</label> Ascension Health , St. Louis , MO Perelman Center for Advanced Medicine , 3400 Civic Center Blvd , Philadelphia , PA 19104.</note>
								<orgName type="department">Perelman Center for Advanced Medicine</orgName>
								<orgName type="institution">Ascension Health</orgName>
								<address>
									<addrLine>3400 Civic Center Blvd</addrLine>
									<postCode>19104.</postCode>
									<settlement>St. Louis Philadelphia</settlement>
									<region>MO PA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<note type="raw_affiliation">Philadelphia , PA ; Philadelphia , Pennsylvania ; St. Louis , MO</note>
								<address>
									<settlement>Philadelphia Philadelphia St. Louis</settlement>
									<region>PA Pennsylvania MO</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_X87ygq8">Gamification-augmented home-based exercise for peripheral ar ter y disease: Rationale and design of the GAMEPAD Study</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">5AFADA5D25DC9C92C0BDF9B71E58E760</idno>
					<idno type="DOI">10.1016/j.ahj.2024.02.003</idno>
					<note type="submission">Submitted January 24, 2024; accepted February 7, 2024</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T08:34+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_WDFzwCZ">Conceptualization</term>
					<term xml:id="_tgT5NeJ">Methodology</term>
					<term xml:id="_zDRshCc">Investigation</term>
					<term xml:id="_SMhHBf4">Wr iting -or iginal draft</term>
					<term xml:id="_9g5Ya6P">Wr itingreview &amp; editing</term>
					<term xml:id="_t7tAMRd">Visualization</term>
					<term xml:id="_5kQvxDe">Project administration</term>
					<term xml:id="_VNsmuTH">Funding acquisition Methodology</term>
					<term xml:id="_3MWSHdq">Formal analysis</term>
					<term xml:id="_A66R7Cm">Data curation</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_RvJUtTh"><p xml:id="_NKmtDff"><s xml:id="_uey2CWf">Background Supervised exercise therapy improves walking performance, functional capacity, and quality of life in patients with peripheral artery disease (PAD).</s><s xml:id="_HbnpJsW">However, few patients with PAD are enrolled in supervised exercise programs, and there are a number of logistical and financial barriers to their participation.</s><s xml:id="_b9QQR8H">A home-based walking intervention is likely to be more accessible to patients with PAD, but no fully home-based walking program has demonstrated efficacy.</s><s xml:id="_DSv9qeN">Concepts from behavioral economics have been used to design scalable interventions that increase daily physical activity in patients with atherosclerotic vascular disease, but whether a similar program would be effective in patients with PAD is uncertain.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ca6As3D">Study Design and Objectives GAMEPAD (NCT04536012</head><p xml:id="_uPQBZsX"><s xml:id="_RnDW2Uy">) is a pragmatic, virtual, randomized controlled trial designed to evaluate the effectiveness of a gamification strategy informed by concepts from behavioral economics to increase daily physical activity in patients with PAD who are seen in cardiology and vascular surgery clinics affiliated with the University of Pennsylvania Health System.</s><s xml:id="_pt65bQn">Patients are contacted by email or text message, and complete enrollment and informed consent on the Penn Way to Health online platform.</s><s xml:id="_DHbxneg">A GAMEPAD substudy will evaluate the effectiveness of opt-in versus opt-out framing when approaching patients for study participation.</s><s xml:id="_bYYNK79">Patients are then provided with a wearable fitness tracker, establish a baseline daily step count, set a goal to increase daily step count by 33%-50%, and are randomized 1:1 to the gamification or control arms.</s><s xml:id="_CBCqtuN">Interventions continue for 16 weeks, including a 4-week period during which goal step count is gradually increased in the gamification arm, with follow-up for an additional 8 weeks to evaluate the durability of behavior change.</s><s xml:id="_4YqBaCC">The trial has met its enrollment goal of 102 participants, with a primary endpoint of change from baseline in daily steps over the 16-week intervention period.</s><s xml:id="_dXH6MDe">Key secondary endpoints include change from baseline in daily steps over the 8-week postintervention follow-up period and changes in patient-reported measures of PAD symptoms and quality of life over the intervention and follow-up periods.</s></p><p xml:id="_N8u3ctf"><s xml:id="_sdUbFpb">Conclusions GAMEPAD is a virtual, pragmatic randomized clinical trial of a novel, fully home-based walking intervention informed by concepts from behavioral economics to increase physical activity and PAD-specific quality of life in patients with PAD.</s><s xml:id="_UStrXsU">Its results will have important implications for the application of behavioral economic concepts to scalable home-based strategies to promote physical activity in patients with PAD and other disease processes where physical activity is limited by exertional symptoms.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_hmfPTqe">Background</head><p xml:id="_kK52x7A"><s xml:id="_pXFqdMB">Per ipheral ar tery disease (PAD), defined as atherosclerotic narrowing or occlusion of at least 1 peripheral artery, affects &gt; 200 million people worldwide and is associated with substantial morbidity and healthcare costs. <ref type="bibr">1 -3</ref> Symptomatic PAD most often involves the lower extremity, and often presents as intermittent claudication, which is characterized by leg soreness or heaviness with ambulation, and often causes substantial functional limitation. <ref type="bibr" target="#b6">4</ref></s><s xml:id="_UrkYqDA">Though a minority of patients with peripheral artery disease have classic intermittent claudication, a greater proportion have lower extremity symptoms, and even those who do not report overt symptoms may have substantial unrecognized functional limitation. <ref type="bibr">4 , 5</ref></s><s xml:id="_yV9jkPn">n patients with intermittent claudication and exertional limb symptoms, randomized controlled trials have demonstrated that supervised exercise therapy improves walking performance, functional capacity, and quality of life. <ref type="bibr">6 -8</ref></s><s xml:id="_SKddGrY">Based on these trials, supervised exercise therapy is a class IA recommendation in the American Heart Association/American College of Cardiology and Society for Vascular Surgery clinical practice guidelines. <ref type="bibr">9 , 10</ref></s><s xml:id="_Ra8XGY4">However, despite the strong evidence in its favor and recent decision by the Centers for Medicare and Medicaid Services to cover supervised exercise for patients with PAD, <ref type="bibr" target="#b13">11</ref> few patients with PAD attend supervised exercise programs due to logistical and financial barriers. <ref type="bibr">12 , 13</ref></s><s xml:id="_UXu8y5n">A home-based walking intervention is likely to be more accessible to patients with PAD, and some studies evaluating hybrid home-and center-based walking have shown promise; <ref type="bibr">8 , 14 -18</ref> however, no fully home-based walking program has proven effective.</s></p><p xml:id="_86N3z9N"><s xml:id="_CG9P7TB">In designing a fully home-based walking program for patients with PAD, it is important to consider barriers that limit exercise in patients with PAD.</s><s xml:id="_vJn9kCd">Claudication or other lower extremity symptoms with exertion represent one barrier to increasing physical activity in these patients, but struggling with behavior change is a universal human tendency.</s><s xml:id="_ET2qMRs">Behavioral economics is a scientific field of inquiry that uses principles from economics and psychology to understand and influence how individuals make decisions.</s><s xml:id="_eCUJVKN">In classical experiments, behavioral economists showed that people commonly make certain decision errors, leading to the concept of "bounded rationality." <ref type="bibr" target="#b21">19</ref></s><s xml:id="_xTuCrqX">For example, individuals are more motivated by immediate rather than delayed gratification, by losses rather than gains, and by the desire to avoid feelings of regret. <ref type="bibr">20 , 21</ref></s><s xml:id="_4yzkrVa">In prior studies, gamification based on behavioral economic concepts increased physical activity more than control in patients with or at risk for ASCVD. <ref type="bibr">22 , 23</ref></s><s xml:id="_txYQQY4">owever, whether such a gamification intervention improves physical activity in patients with PAD, who have both psychological and physiological barriers to increasing exercise, is uncertain.</s></p><p xml:id="_hptkMsm"><s xml:id="_hJpAbvR">We therefore designed the Gamification-Augmented home-based Exercise for Peripheral Artery Disease (GAMEPAD) randomized controlled trial to test the effectiveness of gamification plus automated coaching, compared with control, to increase physical activity over a 16-week intervention with 8-week follow-up in patients with PAD ( Figure <ref type="figure" target="#fig_0">1</ref> ).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_jmwRz5h">Methods</head><p xml:id="_5hBxVRQ"><s xml:id="_nZZeGpu">GAMEPAD is funded by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR001878, and suppor ted in par t by the Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania.</s><s xml:id="_uyTXs7e">Prior to enrollment of the first patient, the trial was registered at clinicaltrials.gov</s><s xml:id="_AeSE8jF">(NCT03911141) and the study protocol was approved by the University of Pennsylvania Institutional Review Board.</s><s xml:id="_6YUVueC">The authors are solely responsible for the design and conduct of this study, all study analyses, the drafting and editing of the paper and its final contents.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_mzWdpCn">Study population</head><p xml:id="_u5NEdaE"><s xml:id="_vCKhNPF">GAMEPAD is recruiting participants with PAD from the more than 60 primary care, cardiology, and vascular surgery practices affiliated with the University of Pennsylvania Health System, located in southeastern Pennsylvania and New Jersey.</s><s xml:id="_CbqzKfB">To increase generalizability, inclusion cr iter ia are broad with few exclusion cr iter ia: Par ticipants are eligible if they are ≥18 years old, own a smartphone or tablet operating the iOS or Android operating system, and have PAD, defined as ankle-brachial index &lt; 0.90, lower extremity CT scan or ultrasound consistent with PAD, angiography with ≥70% stenosis in any lower extremity artery, or a history of medical or surgical revascular ization.</s><s xml:id="_aJfSHQG">The y are excluded if they are unable or unwilling to provide informed consent, have chronic limbthreatening ischemia (defined as rest pain, ulceration, or tissue loss involving the lower extremity), have planned lower extremity revascularization, have prior above or below knee amputation, require a wheelchair or use of a walking aid other than a cane, are currently participating in a supervised exercise program for patients with PAD, have anticipated life expectancy less than 6 months, if they take &gt; 7500 steps/day at baseline, or if there is any other reason why it is not feasible to complete the entire 6-month study.</s></p><p xml:id="_fM43jZc"><s xml:id="_ur4MrTm">Potentially eligible patients are identified using data from the electronic health record (EHR) and the health system's clinical data warehouse, or by direct referral from their cardiologists or vascular surgeons.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_SY6rrAg">Study procedures</head><p xml:id="_2BtbJMc"><s xml:id="_b6MzxHr">After potentially eligible patients are identified via the EHR, they are directly contacted by email or text message.</s><s xml:id="_xM6CsnW">In a substudy of the GAME PAD trial, patients will be randomized to 1 of 2 different messages, framing participation in an opt-in or opt-out manner.</s><s xml:id="_TrKqHJm">Both messages Summary of the design of the GAME PAD trial.</s><s xml:id="_y3XcqtM">Patients with peripheral artery disease (PAD) are eligible for enrollment into GAME PAD.</s><s xml:id="_qyKUx7Z">Patients complete informed consent and baseline questionnaires on the Penn Way to Health platform and are mailed a Fitbit wearable fitness tracker.</s><s xml:id="_ErNgRBh">They wear the fitness tracker for 2 weeks to establish a baseline step count, and patients with baseline step count &gt; 7,500 are excluded.</s><s xml:id="_emsYRRR">The remaining patients set a goal to increase step count by 33%-50% above baseline and are then randomized to gamification + automated coaching or attention control.</s></p><p xml:id="_DDqguTr"><s xml:id="_QMENxkE">introduce the study and provide a link to the study's webpage on Penn Way to Health, <ref type="bibr" target="#b26">24</ref> a research and care delivery platform that automates the delivery of behavior change interventions.</s><s xml:id="_SXv45Xa">Patients randomized to the opt-in approach will be instructed to call a study coordinator or visit the Way to Health platform to enroll in the study; patients randomized to the opt-out study will be notified that they will be called by a study coordinator unless they decline to participate.</s><s xml:id="_uSmhQ8m">Patients referred directly from cardiologists and vascular surgeons are not included in the opt-in versus opt-out substudy, and will be called by a study coordinator to discuss the study and enrollment.</s></p><p xml:id="_3cpRPAd"><s xml:id="_HGxhx4u">All participants enroll via a study webpage on the Way to Health platform.</s><s xml:id="_bW4kHGB">On the study webpage, participants create an account, confirm their eligibility, complete the informed consent process, and answer questions regarding demographics, medical history, health status, and health-related quality of life.</s><s xml:id="_uAqH2Bh">Participants complete the enrollment process on their own, outside of clinical encounters, with study staff available to answer any questions by phone.</s></p><p xml:id="_TTNRYzz"><s xml:id="_RFxxmKf">Once eligible patients complete the baseline questionnaire, they are mailed a wrist-worn activity tracker (Fitbit Charge 5) and instructions for how to connect the device to the Way to Health platform.</s><s xml:id="_PtK98p4">Participants are told to wear the device for 2 weeks to get comfortable using it, but are not explicitly told that baseline physical activity data is collected during this time per iod.</s><s xml:id="_2Scb9dx">Dur ing the second week of this 2-week run-in phase, baseline activity measures (daily step counts, minutes of moderate physical activity) are estimated, as done previously. <ref type="bibr">22 , 25</ref></s><s xml:id="_ABuAsgd">he first week of data is ignored to diminish the potential upward bias of the estimate from higher activity during initial device use.</s><s xml:id="_BexjWTS">To prevent potential mismeasurement, days with step values &lt; 1,000 are ignored, as previous studies have shown that these are unlikely to represent capture of actual activity during the entire day. <ref type="bibr">26 , 27</ref></s><s xml:id="_y8SzxT9">For participants with &lt; 4 days with step count ≥1,000 during the second week of the run-in period, the baseline period is extended until at least 4 valid days of data are collected.</s><s xml:id="_T6GGj4H">Baseline daily step count is calculated as the mean daily step count from the second week of the runin period; days where the participant had a step count &lt; 1,000 are excluded from both the numerator (steps) and the denominator (days).</s><s xml:id="_uN3t5tv">Participants who do not complete the run-in phase or had baseline step counts &gt; 7,500 steps/day are not randomized into the trial and are asked to return their Fitbit device.</s></p><p xml:id="_mVy2dAG"><s xml:id="_jQXExhQ">Once baseline measures are established, participants are contacted via text message or email, given their base-line step count, and asked to set a goal step increase of 33%, 40%, or 50%, or a custom goal at least 1,500 steps greater than baseline.</s><s xml:id="_3Cm9GEc">This approach was selected to give participants the option of setting their own goal, which we have shown is the most effective approach for goalsetting, <ref type="bibr" target="#b25">23</ref> while nudging them to choose between different goals that were ambitious but achievable.</s><s xml:id="_ehrva4r">They are then randomized 1:1 to either gamification + automated coaching or attention control, stratified by baseline step count ( &lt; 2,500 steps, 2,500-5,000 steps, &gt; 5,000 steps) using an electronic number generator through the Way to Health platform.</s><s xml:id="_JTy6qKy">Treatment assignment is necessarily open-label, but patients are not explicitly informed about the existence or details of other treatment arms.</s></p><p xml:id="_GE5r5Qz"><s xml:id="_Dpjsz5q">To achieve their goal, all patients receive a message recommending that they begin walking for 15 minutes daily at their own pain-free pace or with minimal pain, gradually increasing the duration to 30-60 minutes daily.</s><s xml:id="_h9N5BM4">They are told to stop and rest if the pain becomes more significant, then resume walking.</s><s xml:id="_RYpxetG">Though this is not the regimen typically prescribed for supervised exercise therapy-in which patients are usually instructed to walk at a pace that will induce claudication after 5-10 minutes of walking, then rest until claudication resolves, then repeat as necessary to complete a 60-minute session <ref type="bibr" target="#b13">11</ref> -a simpler strategy was selected to facilitate adherence to a walking plan without face-to-face support from an exercise physiologist or other clinician.</s></p><p xml:id="_NqMW6Vv"><s xml:id="_AWxev8s">During the study period, patients are asked to complete questionnaires at 16 and 18 weeks' follow-up.</s><s xml:id="_zgSS56Y">Participants receive $25 for enrolling in the study and completing baseline surveys, $25 for completing the 16-week intervention and 16-week survey with step data available for ≥60% of days, and $25 for completing 24-week survey.</s><s xml:id="_S3zCgHb">Patients are also allowed to keep the Fitbit at the conclusion of the study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_EWz9aXg">Study treatments</head><p xml:id="_s3yNR8f"><s xml:id="_nUc9q6t">In the gamification + automated coaching arm, participants will receive biweekly text messages including encouragement to walk for exercise, reminders about their goal step increase, reminders about optimal practices for home-based walking in patients with PAD, and information about the benefit of exercise in improving PAD symptoms and functional capacity.</s><s xml:id="_DqWrRKG">They will have a 4-week ramp-up toward their step goal.</s><s xml:id="_cxsmCzA">The net difference between baseline and their goal will be divided by 4 and the participant will be asked to achieve the 25% increase each week for the 4-week ramp-up.</s><s xml:id="_R9bDnJj">For example, a participant with a baseline of 5,000 steps and goal of 7,400 steps will be asked to achieve goals of 5,600 steps in week 1, 6,200 in week 2, and so on through the 4-week period.</s><s xml:id="_6v8hrpE">Following the ramp-up period, the participant will be asked to maintain their goal during the remainder of the study.</s></p><p xml:id="_fhfnDaU"><s xml:id="_b7zFKeN">Participants are also entered into a game that leverages insights from behavioral economics to address predictable barriers to behavior change ( Table <ref type="table" target="#tab_0">1</ref> ).</s><s xml:id="_SztQGJX">The components are the following: 1) Precommitment: Each participant signs a contract agreeing to try their best to achieve their daily step goal, an approach shown to motivate behavior change. <ref type="bibr" target="#b30">28</ref></s><s xml:id="_nUAXW3y">2) Points: At the start of each week, the participant receives 70 points (10 for each day of the week).</s><s xml:id="_kwHTuvP">Participants are endowed with points rather than given points after achieving a milestone to leverage loss aversion, a concept from prospect theory that indicates that individuals are more motivated by losses than gains. <ref type="bibr" target="#b22">20</ref></s><s xml:id="_5deMMCX">Each day the participant is informed of their step count from the day prior.</s><s xml:id="_VN74XDh">If the step goal was achieved, the participant retains his or her points; if the step goal was not achieved, they are informed that they lost 10 points.</s><s xml:id="_A6WQaqV">Points are replenished at the start of each week to leverage the "fresh start effect" -the concept that individuals are more motivated for aspirational behavior around temporal landmarks like the start of a new week. <ref type="bibr" target="#b31">29</ref></s><s xml:id="_Rd4ZfTD">3) Levels: At the end of the week, participants with 40 points or more advance 1 level; participants with less than 40 points drop down a level.</s><s xml:id="_Hpck63k">The levels are blue (lowest), bronze, silver, gold, and platinum (highest).</s><s xml:id="_MZvFBu4">Each participant begins in the silver level to create a sense of achievable goals and use loss aversion to motivate ongoing efforts not to lose status. <ref type="bibr" target="#b32">30</ref></s><s xml:id="_nWbVcBm">Every 8 weeks, individuals in the blue and bronze levels are restarted back at silver, and offered a chance to adjust their step goal, as long as they remain within the range of a 33%-50% increase from baseline.</s><s xml:id="_vxkG8Ct">This allows for another "fresh start," creates a new endowment, and avoids participants becoming discouraged if they set their goals too high at the start of the study.</s><s xml:id="_2DWV7QR">4) Supportive sponsor: Each participant selects a family member or friend of their choice who receives a weekly email with the participant's progress, including accumulated points, level in the game, and average step count.</s><s xml:id="_racnM53">The supportive sponsor helps enhance social incentives to motivate the participant toward his or her goal.</s><s xml:id="_tR8y3fC">Prior to starting the study, supportive sponsors participate in a three-way phone call with the participant and study staff to discuss the rules of the game and ways that they can help the participant reach their goals.</s><s xml:id="_ddt5uCF">Every 8 weeks, participants in the blue and bronze levels are contacted, along with their sponsor, to discuss ways the sponsor can better help participants achieve their goals moving forward.</s><s xml:id="_5HcAWdf">The game lasts for the duration of the 16-week intervention.</s><s xml:id="_kAMCDYD">After 16 weeks, the participants in the gamification arm receive a daily text message noting their step count from the day prior for an additional 8-week follow-up period.</s></p><p xml:id="_UdAQYBv"><s xml:id="_bMvyQR2">In the attention control arm, patients receive a text message each day telling them whether they achieved their step goal on the prior day for the entire 24-week study period.</s><s xml:id="_WJsWgp9">People are more motivated when the same situation is framed as a loss rather than a gain</s></p><p xml:id="_YDuxVa8"><s xml:id="_Bb2nn8K">Points are endowed at the beginning of each week and can be lost for not achieving step counts Social ranking Social influences from networks impact people's behavior</s></p><p xml:id="_3bf7rWe"><s xml:id="_q6fmCuX">Participants select a social support partner who will identify ways to help them in their journey and receive a weekly update on their progress.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_CSDKgcb">Goal gradients</head><p xml:id="_c4VTqJM"><s xml:id="_DugSUse">People try harder when goals are within reach Par ticipants star t in the middle level and if they per form poorly, they get a fresh start every 8 weeks, and are moved back to the middle level</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_x6mkTBg">Study endpoints</head><p xml:id="_MRA3PwY"><s xml:id="_Ghajtgp">The primary endpoint is change in mean daily steps from baseline through the 16-week intervention, excluding the 4-week ramp-up phase.</s><s xml:id="_urvXPC4">Other outcomes include change in mean daily steps from baseline through the 24week study period, change in light, moderate, or vigorous physical activity from baseline through the 16-week intervention and 24-week follow-up periods, change in Walking Impairment Questionnaire scores from baseline through 16-week and 24-week follow-up, and change in PROMIS mobility, pain interference, and satisfaction with social roles and activities scores from baseline through 16-week and 24-week follow-up.</s><s xml:id="_VkP5vEF">These outcomes were selected to reflect functional mobility in the community, an outcome of importance to patients with PAD. <ref type="bibr" target="#b33">31</ref> Mean daily steps are captured by the Fitbit devices and automatically uploaded to the Penn Way to Health platform.</s></p><p xml:id="_h439JxD"><s xml:id="_jQZhw25">Step data are transferred to the Way to Health platform every 4 hours.</s><s xml:id="_PGc6dDR">To identify minutes of moderate and vigorous physical activity (MVPA), we will use data established in previous studies validating a threshold of 100 steps per minute as the minimum level of activity to be considered MVPA. <ref type="bibr">32 , 33</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_qRpHPP9">Statistical considerations</head><p xml:id="_5bPFVn9"><s xml:id="_9SuwpDD">The primary analysis will fit generalized linear mixed effect regression models to evaluate changes in physical activity and quality of life outcomes adjusting for each participant's baseline measure, time, and calendar-month fixed effects (fitted as a nominal variable), and participant random effects to account for repeated measures.</s><s xml:id="_FDujMdu">For analyses of daily steps, data captured during the entire study period will be used; this approach increases power by using all participant data, and provides a more complete picture of daily step count over the entire study period.</s><s xml:id="_PgbaDfm">All analyses will be performed according to the intention-to-treat principle.</s></p><p xml:id="_xTeDBpS"><s xml:id="_bYzJjQ4">Patients with PAD walk approximately 3,900 steps/day (SD 2,689 steps). <ref type="bibr" target="#b19">17</ref></s><s xml:id="_dCtGs8r">With a home-based exercise program, the mean change in steps/day over 4.5 months for patients with PAD was a decrease by 200 steps (SD ∼2,000 steps). <ref type="bibr" target="#b19">17</ref></s><s xml:id="_Y2YYQVg">With 100 patients (50 in each arm), the study will have approximately 80% power to detect an 1,100 step difference in change in daily step count between the 2 arms with alpha set at 0.05.</s></p><p xml:id="_pMyFbAR"><s xml:id="_f9uhNkd">As in prior studies with similar design, <ref type="bibr">23 , 34</ref> our approach to handling days with missing step count data will be to impute daily step counts for these days in our primary analysis, using an imputation model that includes study arm, calendar month (fitted as a nominal variable), week of study, baseline daily steps, age, sex, race/ethnicity, educational level, marital status, household income level, selfreported health, and participant random effect.</s><s xml:id="_TSJmnFk">We will also perform a sensitivity analysis that uses collected data without imputation (such that days with missing step counts are recorded as zero steps).</s><s xml:id="_AFE2QMu">In prior studies using similar statistical methods, results of such sensitivity analyses have been similar to the primary analyses. <ref type="bibr">23 , 34</ref></s><s xml:id="_EFVGrZv">or the opt-in versus opt-out recruitment substudy, the primary outcome will be the proportion of patients who enroll in the study as a fraction of all patients contacted, compared between potential participants randomized to opt-in versus opt-out framing.</s><s xml:id="_zaRFHzM">We will also test for an interaction between method of recruitment (opt-in versus opt-out) and the effect of the intervention on the primary outcome of change from baseline in mean daily steps.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_x3RZTgn">Trial status</head><p xml:id="_mSmfmT9"><s xml:id="_Wrtp4Af">The tr ial star ted enrollment in October 2020 and completed enrollment in July 2023.</s><s xml:id="_EXTfEwU">Ultimately, 102 patients were enrolled, as patients in the baseline phase when the trial reached its recruitment goal were allowed to continue in the study.</s><s xml:id="_PDcxVtC">The last patient enrolled will fin-  <ref type="bibr" target="#b37">35</ref> The mean participant took 4,385 ± 2,041 steps during the baseline run-in period and set a goal of increasing steps by 1,356 ± 1,555 during the study period.</s></p><p xml:id="_skgEEgP"><s xml:id="_jsrP4fs">To date, 94% of participants randomized have remained in the study through 18-week follow-up, and 95% of par-ticipants submitted step count data for ≥ 60% of days through the 16-week intervention period.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_N7aR6mn">Conclusions</head><p xml:id="_mrnyUKK"><s xml:id="_N8u4vtp">The GAME PAD trial, a randomized trial of an entirely home-based walking program for patients with PAD informed by concepts from behavioral economics, will provide several important insights.</s><s xml:id="_9NUSYSw">From the standpoint of clinical practice, few eligible patients with PAD participate in supervised exercise programs, and there are substantial barriers to participation, <ref type="bibr" target="#b14">12</ref> particularly for Black, rural, and low socioeconomic status patients, groups with particularly poor PAD outcomes. <ref type="bibr" target="#b38">36</ref></s><s xml:id="_6Xkjbvy">Some homebased exercise programs demonstrate promise, but all previously tested home-based exercise programs involve multiple visits to a centralized supervised exercise center and live consultation with an exercise specialist.</s><s xml:id="_FYMNrxM">Requirements for multiple visits may limit participation for many patients, and the need for specialized exercise specialists may strain resources for some health systems.</s><s xml:id="_kjEBJXu">By contrast, GAME PAD is the first trial to test an entirely home-based and virtual physical activity program in patients with PAD, and does not require access to exercise specialists.</s><s xml:id="_jTmjvY7">Should this intervention prove effective, it could be deployed even in communities without access to vascular subspecialists or supervised exercise therapy.</s><s xml:id="_X3k4fRS">Moreover, though other studies have demonstrated the effectiveness of physical activity programs informed by behavioral economic theory to increase physical activity in patients with or at risk for atherosclerotic cardiovascular disease, GAME PAD seeks to expand this paradigm to patients whose physical activity is limited by exertional symptoms.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1</head><label>1</label><figDesc><div><p xml:id="_9eHUJUs"><s xml:id="_GQ4gYHZ">Figure 1</s></p></div></figDesc><graphic coords="3,71.15,115.28,456.00,229.05" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_RjfMdU2"><s xml:id="_NVQMyp9">Behavioral economic principles used to inform the design of the interventions</s></p></div></figDesc><table><row><cell>Principle</cell><cell>Predictably irrational tendency</cell><cell>Implications for intervention design</cell></row><row><cell>Status quo bias</cell><cell>People favor the path of least resistance and avoid</cell><cell>Without the intervention, patients are unlikely to</cell></row><row><cell></cell><cell>initiating change</cell><cell>change their physical activity; therefore, the</cell></row><row><cell></cell><cell></cell><cell>gamification intervention runs automatically rather than</cell></row><row><cell></cell><cell></cell><cell>requiring the individual to actively participate, other</cell></row><row><cell></cell><cell></cell><cell>than by working to achieve their physical activity goals</cell></row><row><cell>Immediacy</cell><cell>Immediate rewards are more motivating than</cell><cell>Points are rewarded every day to create an immediate</cell></row><row><cell></cell><cell>rewards far into the future (e.g. health outcomes)</cell><cell>'benefit' that links to future benefits</cell></row><row><cell>Loss aversion</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p xml:id="_Bm4ExYb"><s xml:id="_86Kykjg">Baseline characteristics of enrolled patients</s></p></div></figDesc><table><row><cell>Baseline characteristics</cell><cell>Total (n = 102)</cell></row><row><cell>Age</cell><cell>69.4 ± 8.6</cell></row><row><cell>Male</cell><cell>53 (52.0)</cell></row><row><cell>Race</cell><cell></cell></row><row><cell>White</cell><cell>80 (78.4)</cell></row><row><cell>Black</cell><cell>16 (15.7)</cell></row><row><cell>Asian</cell><cell>2 (2.0)</cell></row><row><cell>Hispanic</cell><cell>1 (1.0)</cell></row><row><cell>Other</cell><cell>3 (2.9)</cell></row><row><cell>Education</cell><cell></cell></row><row><cell>Some high school</cell><cell>2 (2.0)</cell></row><row><cell>High school graduate</cell><cell>14 (13.7)</cell></row><row><cell>Some college</cell><cell>32 (31.4)</cell></row><row><cell>College graduate</cell><cell>54 (52.9)</cell></row><row><cell>Annual household income</cell><cell></cell></row><row><cell>&lt; $50,000</cell><cell>34 (33.3)</cell></row><row><cell>$50,000 to $100,000</cell><cell>34 (33.3)</cell></row><row><cell>&gt; $100,000</cell><cell>34 (33.3)</cell></row><row><cell>BMI</cell><cell>30.0 ± 6.3</cell></row><row><cell>Current smoking</cell><cell>11 (10.8)</cell></row><row><cell>Hypertension</cell><cell>82 (80.4)</cell></row><row><cell>Hyperlipidemia</cell><cell>72 (70.6)</cell></row><row><cell>Diabetes</cell><cell>37 (36.2)</cell></row><row><cell>Prior MI</cell><cell>26 (25.5)</cell></row><row><cell>Stroke</cell><cell>12 (11.8)</cell></row><row><cell>Heart failure</cell><cell>12 (11.8)</cell></row><row><cell>COPD</cell><cell>19 (18.6)</cell></row><row><cell>Kidney disease</cell><cell>19 (18.6)</cell></row><row><cell>Baseline daily step count</cell><cell>4385 ± 2041</cell></row><row><cell>Goal step increase</cell><cell>1356 ± 1555</cell></row><row><cell>Walking impairment questionnaire</cell><cell></cell></row><row><cell>Distance</cell><cell>44.3 ± 33.9</cell></row><row><cell>Speed</cell><cell>37.6 ± 24.7</cell></row><row><cell>Stairs</cell><cell>44.7 ± 28.3</cell></row><row><cell>Overall</cell><cell>42.2 ± 25.5</cell></row><row><cell>San Diego claudication questionnaire</cell><cell></cell></row><row><cell>Classic claudication</cell><cell>20 (19.6)</cell></row><row><cell>Atypical leg pain</cell><cell>72 (70.6)</cell></row><row><cell>No symptoms</cell><cell>10 (9.8)</cell></row><row><cell cols="2">ish follow up in January 2024. Baseline characteristics</cell></row><row><cell cols="2">of tr ial par ticipants are shown in Table 2 . Participants'</cell></row><row><cell cols="2">mean ± standard deviation age is 69.4 ± 8.6; 48.0% of</cell></row><row><cell cols="2">participants are female, 15.7% are Black, 36.2% have dia-</cell></row><row><cell cols="2">betes, 80.4% hypertension, and 25.4% prior MI. Overall,</cell></row><row><cell cols="2">19.6% of participants reported classic claudication symp-</cell></row><row><cell cols="2">toms, and 9.8% reported no lower extremity symptoms</cell></row><row><cell cols="2">with walking. Scores on the Walking Impairment Ques-</cell></row><row><cell cols="2">tionnaire were 44.3 ± 33.9 on the distance subscale, 37.6</cell></row><row><cell cols="2">± 24.7 on the speed subscale, 44.7 ± 28.3 on the stairs</cell></row><row><cell cols="2">subscale, and 42.2 ± 25.5 overall. Though GAMEPAD did</cell></row><row><cell cols="2">not require patients to have symptoms with walking to</cell></row><row><cell cols="2">be enrolled, these scores are similar to those observed in</cell></row><row><cell>cohorts of patients with symptomatic PAD.</cell><cell></cell></row></table></figure>
		</body>
		<back>


			<div type="funding">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_B8BCD6v">Funding</head></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_6Je4NRx">Conflict of Interest</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_TweaxVP">Writing -review &amp; editing</title>
		<author>
			<persName><forename type="first">Jingsan</forename><surname>Zhu</surname></persName>
		</author>
		<idno type="DOI">10.1044/2022_ajslp-21-00361</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FDJ5JyE">Methodology, Formal analysis, Data curation</title>
		<imprint/>
	</monogr>
	<note type="raw_reference">Jingsan Zhu: Writing -review &amp; editing, Methodol- ogy, Formal analysis, Data curation.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_CMuedNr">Writing -review &amp; editing</title>
		<author>
			<persName><forename type="first">G</forename><surname>Michael</surname></persName>
		</author>
		<author>
			<persName><surname>Levin</surname></persName>
		</author>
		<idno type="DOI">10.1044/2022_ajslp-21-00361</idno>
	</analytic>
	<monogr>
		<title level="m" xml:id="_QSaANTe">Writing -review &amp; editing, Investigation, Conceptualization</title>
		<editor>
			<persName><forename type="first">Benjamin</forename><forename type="middle">M</forename><surname>Jackson</surname></persName>
		</editor>
		<imprint/>
	</monogr>
	<note>Investigation Writing -review &amp; editing Writing -review &amp; editing, Investigation, Conceptualization</note>
	<note type="raw_reference">Michael G. Levin: Writing -review &amp; editing, Investigation. Scott M. Dam- rauer: Writing -review &amp; editing, Investigation. Jay S. Giri: Writing -review &amp; editing, Investigation. Neel P. Chokshi: Writing -review &amp; editing, Investigation, Con- ceptualization. Benjamin M. Jackson: Writing -review &amp; editing, Investigation, Conceptualization.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<author>
			<persName><forename type="first">S</forename><surname>Mitesh</surname></persName>
		</author>
		<author>
			<persName><surname>Patel</surname></persName>
		</author>
		<title level="m" xml:id="_W7vZCMe">Writing -review &amp; editing, Investigation, Funding acquisition, Conceptualization</title>
		<imprint/>
	</monogr>
	<note type="raw_reference">Mitesh S. Patel: Writing -review &amp; editing, Investigation, Funding acquisition, Conceptualization. References</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_9UmGwg6">Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis</title>
		<author>
			<persName><forename type="first">Fgr</forename><surname>Fowkes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Rudan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Rudan</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(13)61249-0</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gBNVPXy">Lancet</title>
		<imprint>
			<biblScope unit="volume">382</biblScope>
			<biblScope unit="page" from="1329" to="1340" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fowkes FGR, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013;382:1329-40 .</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_U6Yw7p2">Estimated annual health care expenditures in individuals with peripheral arterial disease</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Scully</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Arnaoutakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Debord</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.jvs.2017.06.102</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_p5U8emx">J Vasc Surg</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="558" to="567" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Scully RE, Arnaoutakis DJ, DeBord Smith A, et al. Estimated annual health care expenditures in individuals with peripheral arterial disease. J Vasc Surg 2018;67:558-67 .</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_YCAHNZv">Burden of peripheral arterial disease in Europe and the United States: a patient survey</title>
		<author>
			<persName><forename type="first">E</forename><surname>Marrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1186/1477-7525-11-175</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_eNkf3RH">Health Qual Life Outcomes</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">175</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Marrett E, DBM daCosta, Zhang Q. Burden of peripheral arterial disease in Europe and the United States: a patient survey. Health Qual Life Outcomes. 2013;11:175.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_SNyyNyd">Leg symptoms in peripheral arterial disease associated clinical characteristics and functional impairment</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Mcdermott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Greenland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TVXUjNV">JAMA</title>
		<imprint>
			<biblScope unit="volume">286</biblScope>
			<biblScope unit="page" from="1599" to="1606" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McDermott MM, Greenland P, Liu K, et al. Leg symptoms in peripheral arterial disease associated clinical characteristics and functional impairment. JAMA 2001;286:1599-606 .</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_mNspmP7">Leg symptom categories and rates of mobility decline in peripheral arterial disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Mcdermott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ferrucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Liu</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1532-5415.2010.02941.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_u2nu7q6">J Am Geriatr Soc</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="1256" to="1262" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McDermott MM, Ferrucci L, Liu K, et al. Leg symptom categories and rates of mobility decline in peripheral arterial disease. J Am Geriatr Soc 2010;58:1256-62 .</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_CjrfxZc">Supervised walking therapy in patients with intermittent claudication</title>
		<author>
			<persName><forename type="first">F</forename><surname>Fakhry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Van De Luijtgaarden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bax</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jvs.2012.04.046</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QNwFme7">J Vasc Surg</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="1132" to="1142" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fakhry F, van de Luijtgaarden KM, Bax L, et al. Supervised walking therapy in patients with intermittent claudication. J Vasc Surg 2012;56:1132-42 .</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_hKBVNQ7">Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Mcdermott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ades</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Guralnik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qG2p4Px">JAMA</title>
		<imprint>
			<biblScope unit="volume">301</biblScope>
			<biblScope unit="page" from="165" to="174" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McDermott MM, Ades P, Guralnik JM, et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA 2009;301:165-74 .</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_SU7wXcD">Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Mcdermott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Guralnik</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2013.7231</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Ccv9VFb">JAMA</title>
		<imprint>
			<biblScope unit="volume">310</biblScope>
			<biblScope unit="page" from="57" to="65" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McDermott MM, Liu K, Guralnik JM, et al. Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial. JAMA 2013;310:57-65 .</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_CTQYVCS">AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines</title>
		<author>
			<persName><forename type="first">Gerhard-Herman Md</forename><surname>Gornik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Barrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
		<idno type="DOI">10.1161/cir.0000000000000502</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5Kwb6Qd">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="71" to="126" />
			<date type="published" when="2016">2016. 2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol 2017;69:e71-126 .</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_xmBrCXW">Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Conte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">B</forename><surname>Pomposelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Clair</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jvs.2014.12.009</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pSppMam">J Vasc Surg</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="2S" to="41S" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
	<note type="raw_reference">Conte MS, Pomposelli FB, Clair DG, et alSociety for Vascular Surgery Lower Extremity Guidelines Writing Group. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg 2015;61 2S-41S, Suppl .</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_y7nYfUD">Implementation of supervised exercise therapy for patients with symptomatic peripheral artery disease: a science advisory from the American Heart Association</title>
		<author>
			<persName><forename type="first">D</forename><surname>Treat-Jacobson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Mcdermott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Beckman</surname></persName>
		</author>
		<idno type="DOI">10.1161/cir.0000000000000727</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hpQGKwx">Circulation</title>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="page" from="700" to="710" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Treat-Jacobson D, McDermott MM, Beckman JA, et al. Implementation of supervised exercise therapy for patients with symptomatic peripheral artery disease: a science advisory from the American Heart Association. Circulation. 2019;140:e700-10 .</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_x8xUw8E">A systematic review of the uptake and adherence rates to supervised exercise programs in patients with intermittent claudication</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Harwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Cayton</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.avsg.2016.02.009</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CcuuXPz">Ann Vasc Surg</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="280" to="289" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Harwood AE, Smith GE, Cayton T, et al. A systematic review of the uptake and adherence rates to supervised exercise programs in patients with intermittent claudication. Ann Vasc Surg 2016;34:280-9 .</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_f7sYeZ4">Adherence to guideline-recommended therapy-including supervised exercise therapy referral-across peripheral artery disease specialty clinics: insights from the international PORTRAIT registry</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Saxon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Safley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mena-Hurtado</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jvs.2020.02.007</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cKsCY7G">J Am Heart Assoc [Internet</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">12541</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Saxon JT, Safley DM, Mena-Hurtado C, et al. Adherence to guideline-recommended therapy-including supervised exercise therapy referral-across peripheral artery disease specialty clinics: insights from the international PORTRAIT registry. J Am Heart Assoc [Internet] 2020;9:e012541 .</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_YkvZ4az">Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Gardner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Montgomery</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.110.963066</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Sa89PGd">Circulation</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="491" to="498" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gardner AW, Parker DE, Montgomery PS, et al. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial. Circulation 2011;123:491-8 .</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_SVtJwRR">Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Gardner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Montgomery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Blevins</surname></persName>
		</author>
		<idno type="DOI">10.1161/jaha.114.001107</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BnDjfFf">J Am Heart Assoc</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">e001107</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gardner AW, Parker DE, Montgomery PS, Blevins SM. Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial. J Am Heart Assoc 2014;3:e001107 .</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_dRdXRX6">Effects of a home-based walking intervention on mobility and quality of life in people with diabetes and peripheral arterial disease: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lunos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Carlson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_W557cry">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="2174" to="2179" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Collins TC, Lunos S, Carlson T, et al. Effects of a home-based walking intervention on mobility and quality of life in people with diabetes and peripheral arterial disease: a randomized controlled trial. Diabetes Care 2011;34:2174-9 .</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_C6wxgDm">Effect of a home-based exercise intervention of wearable technology and telephone coaching on walking performance in peripheral artery disease: the HONOR randomized clinical trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Mcdermott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Spring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Berger</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jvs.2018.07.014</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HJvskex">JAMA</title>
		<imprint>
			<biblScope unit="volume">319</biblScope>
			<biblScope unit="page" from="1665" to="1676" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McDermott MM, Spring B, Berger JS, et al. Effect of a home-based exercise intervention of wearable technology and telephone coaching on walking performance in peripheral artery disease: the HONOR randomized clinical trial. JAMA 2018;319:1665-76 .</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_jGjPy6M">Effect of low-intensity vs high-intensity home-based walking exercise on walk distance in patients with peripheral artery disease: the LITE randomized clinical trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Mcdermott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Spring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_w7sXukN">JAMA</title>
		<imprint>
			<biblScope unit="volume">325</biblScope>
			<biblScope unit="page" from="1266" to="1276" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McDermott MM, Spring B, Tian L, et al. Effect of low-intensity vs high-intensity home-based walking exercise on walk distance in patients with peripheral artery disease: the LITE randomized clinical trial. JAMA 2021;325:1266-76 .</note>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title level="m" type="main" xml:id="_R2tf4TH">Thinking, fast and slow</title>
		<author>
			<persName><forename type="first">D</forename><surname>Kahneman</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2011">2011</date>
			<publisher>Farrar, Straus and Giroux</publisher>
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Kahneman D. Thinking, fast and slow . New York: Farrar, Straus and Giroux; 2011 .</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_YuEHUUr">Prospect theory: an analysis of decision under risk</title>
		<author>
			<persName><forename type="first">D</forename><surname>Kahneman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tversky</surname></persName>
		</author>
		<idno type="DOI">10.2307/1914185</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nAs8Sss">Econometrica</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="263" to="291" />
			<date type="published" when="1979">1979</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica 1979;47:263-91 .</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_DUBTAus">Anomalies: the endowment effect, loss aversion, and status quo bias</title>
		<author>
			<persName><forename type="first">D</forename><surname>Kahneman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Knetsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Thaler</surname></persName>
		</author>
		<idno type="DOI">10.1257/jep.5.1.193</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_H6byRhx">J Econ Perspect</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="193" to="206" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kahneman D, Knetsch JL, Thaler RH. Anomalies: the endowment effect, loss aversion, and status quo bias. J Econ Perspect 1991;5:193-206 .</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_B9qj5Yg">Loss-framed financial incentives and personalized goal-setting to increase physical activity among ischemic heart disease patients using wearable devices: the ACTIVE REWARD randomized trial</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Chokshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Adusumalli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Small</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WcTHc7x">J Am Heart Assoc</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e009173</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chokshi NP, Adusumalli S, Small DS, et al. Loss-framed financial incentives and personalized goal-setting to increase physical activity among ischemic heart disease patients using wearable devices: the ACTIVE REWARD randomized trial. J Am Heart Assoc 2018;7:e009173 .</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_hfwaCxU">Effect of goal-setting approaches within a gamification intervention to increase physical activity among economically disadvantaged adults at elevated risk for major adverse cardiovascular events: the ENGAGE randomized clinical trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bachireddy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Small</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamacardio.2021.3176</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qBTvE4M">JAMA Cardiol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="1387" to="1396" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Patel MS, Bachireddy C, Small DS, et al. Effect of goal-setting approaches within a gamification intervention to increase physical activity among economically disadvantaged adults at elevated risk for major adverse cardiovascular events: the ENGAGE randomized clinical trial. JAMA Cardiol 2021;6:1387-96 .</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_v99zrtr">On the way to health</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_E98Kc5q">LDI Issue Brief</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1" to="4" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Asch DA, Volpp KG. On the way to health. LDI Issue Brief 2012;17:1-4 .</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_UWTrtpT">Effect of a game-based intervention designed to enhance social incentives to increase physical activity among families: the BE FIT randomized clinical trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Benjamin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2017.3458</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uDrTcvd">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">177</biblScope>
			<biblScope unit="page" from="1586" to="1593" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Patel MS, Benjamin EJ, Volpp KG, et al. Effect of a game-based intervention designed to enhance social incentives to increase physical activity among families: the BE FIT randomized clinical trial. JAMA Intern Med 2017;177:1586-93 .</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_HcWCBJx">Pedometer-measured physical activity and health behaviors in U.S. adults</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Bassett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Wyatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Thompson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NvKEwUc">Med Sci Sports Exerc</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="1819" to="1825" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bassett DR, Wyatt HR, Thompson H, et al. Pedometer-measured physical activity and health behaviors in U.S. adults. Med Sci Sports Exerc 2010;42:1819-25 .</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_TeM3ajF">Individual information-centered approach for handling physical activity missing data</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Rowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">V</forename><surname>Barreira</surname></persName>
		</author>
		<idno type="DOI">10.1080/02701367.2009.10599546</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8J9Veth">Res Q Exerc Sport</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="131" to="137" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kang M, Rowe DA, Barreira TV, et al. Individual information-centered approach for handling physical activity missing data. Res Q Exerc Sport 2009;80:131-7 .</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_sgWzuxP">Commitment devices: using initiatives to change behavior</title>
		<author>
			<persName><forename type="first">T</forename><surname>Rogers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Milkman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zbCnbrA">JAMA</title>
		<imprint>
			<biblScope unit="volume">311</biblScope>
			<biblScope unit="page" from="2065" to="2066" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rogers T, Milkman KL, Volpp KG. Commitment devices: using initiatives to change behavior. JAMA 2014;311:2065-6 .</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_vWJJ6Gn">Put your imperfections behind you: temporal landmarks spur goal initiation when they signal new beginnings</title>
		<author>
			<persName><forename type="first">H</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Milkman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Riis</surname></persName>
		</author>
		<idno type="DOI">10.1177/0956797615605818</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8S7w84z">Psychol Sci</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1927" to="1936" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dai H, Milkman KL, Riis J. Put your imperfections behind you: temporal landmarks spur goal initiation when they signal new beginnings. Psychol Sci 2015;26:1927-36 .</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_xBs55vg">Validation of the theoretical domains framework for use in behaviour change and implementation research</title>
		<author>
			<persName><forename type="first">J</forename><surname>Cane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Connor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Michie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8aHR8qF">Implementation Sci</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">37</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cane J, O&apos;Connor D, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation research. Implementation Sci 2012;7:37 .</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_JsYCJUh">PORTRAIT (patient-centered outcomes related to treatment practices in peripheral arterial disease: investigating trajectories)</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Smolderen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Gosch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Patel</surname></persName>
		</author>
		<idno type="DOI">10.1161/circoutcomes.117.003860</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RtqZwME">Circulation: Cardiovasc Qual Outcom</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">3860</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Smolderen KG, Gosch K, Patel M, et al. PORTRAIT (patient-centered outcomes related to treatment practices in peripheral arterial disease: investigating trajectories). Circulation: Cardiovasc Qual Outcom 2018;11:e003860 .</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_E8HjB4T">Translating physical activity recommendations into a pedometer-based step goal: 3000 steps in 30 minutes</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Marshall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Tudor-Locke</forename><surname>Ce</surname></persName>
		</author>
		<idno type="DOI">10.4016/12729.22</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_sM4nPTq">Am J Prev Med</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="410" to="415" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Marshall SJ, Levy SS, Tudor-Locke CE, et al. Translating physical activity recommendations into a pedometer-based step goal: 3000 steps in 30 minutes. Am J Prev Med 2009;36:410-15 .</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_yrBh9Ww">Pedometer-determined step count guidelines for classifying walking intensity in a young ostensibly healthy population</title>
		<author>
			<persName><forename type="first">C</forename><surname>Tudor-Locke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Sisson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Collova</surname></persName>
		</author>
		<idno type="DOI">10.1139/h05-147</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PEtpKEn">Can J Appl Physiol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="666" to="676" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tudor-Locke C, Sisson SB, Collova T, et al. Pedometer-determined step count guidelines for classifying walking intensity in a young ostensibly healthy population. Can J Appl Physiol 2005;30:666-76 .</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_F8SV4je">Effectiveness of behaviorally designed gamification interventions with social incentives for increasing physical activity among overweight and obese adults across the United States: the STEP UP randomized clinical trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Small</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Harrison</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2019.3505</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TmR2WmZ">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">179</biblScope>
			<biblScope unit="page" from="1624" to="1632" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Patel MS, Small DS, Harrison JD, et al. Effectiveness of behaviorally designed gamification interventions with social incentives for increasing physical activity among overweight and obese adults across the United States: the STEP UP randomized clinical trial. JAMA Intern Med 2019;179:1624-32 .</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_b9axRjP">Measurement of walking endurance and walking velocity with questionnaire: validation of the walking impairment questionnaire in men and women with peripheral arterial disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Mcdermott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Guralnik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9KdjUWt">J Vasc Surg</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="1072" to="1081" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McDermott MM, Liu K, Guralnik JM, et al. Measurement of walking endurance and walking velocity with questionnaire: validation of the walking impairment questionnaire in men and women with peripheral arterial disease. J Vasc Surg 1998;28:1072-81 .</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_SdFVwJd">Geographic and socioeconomic disparities in major lower extremity amputation rates in metropolitan areas</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Fanaroff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Nathan</surname></persName>
		</author>
		<idno type="DOI">10.1161/jaha.121.021456</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_F53qWgR">J Am Heart Assoc</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">21456</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fanaroff AC, Yang L, Nathan AS, et al. Geographic and socioeconomic disparities in major lower extremity amputation rates in metropolitan areas. J Am Heart Assoc 2021;10:e021456 .</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
